Clinicopathological characteristics of HER2-low breast cancer: a retrospective study

Human Epidermal Growth Factor Receptor-2 (HER2)-negative breast cancers (BCs) contain HER2-low and HER2-zero ones. HER2-low breast cancer has been receiving wide-spread concerns as the marvelous effect of novel anti-HER2 antibody-drug conjugates, however, the characteristic remains unknown. Our aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Man, Sun, Jiale, Liu, Liqiong, Kong, Xiangyi, Lin, Dongcai, Zhou, Hong, Gao, Jidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390573/
https://www.ncbi.nlm.nih.gov/pubmed/37524746
http://dx.doi.org/10.1038/s41598-023-39372-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390573/
https://www.ncbi.nlm.nih.gov/pubmed/37524746
http://dx.doi.org/10.1038/s41598-023-39372-3

Ejemplares similares